ViewRay, Inc. revised earnings guidance for the fiscal year 2023. For the year, the Company is reducing its revenue guidance range to approximately zero to 15% growth for fiscal 2023 compared to its previous guidance range of 25% to 40% growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% |
|
0.00% | 0.00% |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 12 | Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products | MT |
1st Jan change | Capi. | |
---|---|---|
0.00% | 183 | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+0.80% | 63.2B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B |
- Stock Market
- Equities
- VRAYQ Stock
- News ViewRay, Inc.
- ViewRay, Inc. Revises Earnings Guidance for the Fiscal Year 2023